Free Trial

NeuroSense Therapeutics (NRSN) SEC Filings & 10K Form

NeuroSense Therapeutics logo
$1.52 +0.06 (+4.11%)
Closing price 05/23/2025 03:59 PM Eastern
Extended Trading
$1.54 +0.02 (+1.64%)
As of 05/23/2025 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent NeuroSense Therapeutics SEC Filings

DateFilerForm TypeView
05/07/2025
8:10 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/24/2025
8:25 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/16/2025
11:15 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form EFFECT
04/16/2025
11:15 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form EFFECT
04/11/2025
3:00 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form POS AM
04/11/2025
3:00 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form POS AM
04/07/2025
4:25 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/27/2025
7:00 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/19/2025
7:00 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/19/2025
8:13 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/16/2025
11:15 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form EFFECT
01/06/2025
9:40 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/26/2024
3:47 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
12/23/2024
8:04 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/18/2024
10:06 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/17/2024
1:42 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/12/2024
11:15 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form EFFECT
12/12/2024
4:08 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 424B3
12/04/2024
7:32 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/02/2024
3:15 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/24/2024
11:15 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form EFFECT
11/22/2024
3:30 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 424B3
10/31/2024
3:59 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/30/2024
8:45 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/28/2024
7:35 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/24/2024
7:30 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/15/2024
8:35 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/09/2024
8:13 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/06/2024
11:15 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form EFFECT
10/01/2024
5:00 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form POS AM
09/30/2024
3:53 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/24/2024
8:25 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/16/2024
5:10 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/09/2024
5:10 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/30/2024
4:00 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/28/2024
6:05 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/26/2024
7:00 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/07/2024
8:00 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/01/2024
8:24 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/09/2024
8:29 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/03/2024
8:11 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
The “80/20” stock calendar (Ad)

Imagine having a “trading calendar” with what could be the EXACT dates to buy and sell some of your favorite stocks… I’m talking about popular stocks like Apple, Walmart and even Google! Imagine being able to hone in on the only days of the year that our backtesting has found are historically shown to yield the BIGGEST opportunities... With these unique sheets in your hands, designed to help you decide when to confidently enter AND exit trades... Sounds crazy? The crazy thing is that this ability exists RIGHT NOW.

You can see what I mean when you click right here
07/01/2024
7:05 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/27/2024
7:20 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 424B3
06/27/2024
7:00 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/27/2024
7:16 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 424B3
06/24/2024
8:20 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/21/2024
3:42 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/17/2024
4:24 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 424B3
06/17/2024
4:25 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 424B3
06/17/2024
4:22 PM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2024
6:14 AM
NeuroSense Therapeutics (Filer)
NeuroSense Therapeutics Ltd. (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NRSN) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners